National Research (NRCIB) Earning Positive Media Coverage, Study Shows

News headlines about National Research (NASDAQ:NRCIB) have been trending positive on Thursday, AlphaOne Sentiment Analysis reports. The research group, a unit of Accern, rates the sentiment of media coverage by analyzing more than twenty million news and blog sources in real time. AlphaOne ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. National Research earned a media sentiment score of 0.31 on AlphaOne’s scale. AlphaOne also gave news articles about the business services provider an impact score of 0 out of 100, indicating that recent media coverage is extremely unlikely to have an effect on the company’s share price in the near term.

Shares of National Research (NASDAQ:NRCIB) traded up 0.02% on Thursday, reaching $41.51. The company’s stock had a trading volume of 337 shares. The stock has a market cap of $1.01 billion, a PE ratio of 50.19 and a beta of 0.33. National Research has a 1-year low of $32.18 and a 1-year high of $46.37. The company’s 50 day moving average is $40.30 and its 200-day moving average is $39.44.

National Research (NASDAQ:NRCIB) last announced its quarterly earnings results on Tuesday, February 14th. The business services provider reported $0.23 earnings per share for the quarter, topping analysts’ consensus estimates of $0.22 by $0.01. The firm had revenue of $28.37 million for the quarter. National Research had a return on equity of 35.36% and a net margin of 18.99%. On average, equities analysts predict that National Research will post $0.92 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, April 14th. Shareholders of record on Friday, March 31st were given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 5.78%. The ex-dividend date was Wednesday, March 29th. National Research’s dividend payout ratio (DPR) is presently 500.00%.

Several brokerages have weighed in on NRCIB. Zacks Investment Research lowered National Research from a “strong-buy” rating to a “hold” rating in a research report on Wednesday. First Analysis lowered National Research from an “overweight” rating to an “equal weight” rating and set a $44.00 target price on the stock. in a research report on Thursday, February 16th.

ILLEGAL ACTIVITY NOTICE: “National Research (NRCIB) Earning Positive Media Coverage, Study Shows” was reported by WKRB News and is the property of of WKRB News. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US & international copyright legislation. The legal version of this piece of content can be accessed at

National Research Co is a business services company in the Health Care Services industry.

5 Day Chart for NASDAQ:NRCIB

This story was originally published by WKRB News ( and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at

Receive News & Ratings for National Research Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research Co. and related companies with's FREE daily email newsletter.


Leave a Reply

© 2006-2017 WKRB News.